Viewing nowGasdin Tablets 2mg (Irsogladine Maleate)
Irsogladine Maleate 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

MFDS item code 201307888 · Approved 2013.06.27 · Insurance code 642403700
Improves gastric mucosal lesions in gastritis (such as erosions and bleeding); treats gastric ulcers
This medication is used to improve gastric mucosal lesions such as erosion, bleeding, redness, and swelling that appear during acute exacerbations of gastric ulcers and acute or chronic gastritis.
1) Gastric ulcer (Adults) Administer 4mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, and edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4mg of irsogladine maleate orally in 1∼2 divided doses daily.
This medication contains lactose and should not be used by patients with genetic disorders that impair lactose digestion. For example, individuals with galactose intolerance, congenital lactase deficiency, or glucose-galactose malabsorption may experience health issues if this medication is taken. When taking this medication, side effects such as abnormal liver function, constipation, rash, itching, and diarrhea may occur. Abnormal liver function may present as elevated liver enzyme levels in blood tests, so caution is needed. Rarely, symptoms such as dizziness, drowsiness, abdominal distension, decreased appetite, and dry mouth have been reported. Elderly patients may have decreased physical function, so treatment should start with a lower dose and be carefully monitored. Women who are pregnant or may become pregnant should only use this medication when the therapeutic benefits outweigh the potential risks to the fetus, as the effects on the fetus are not well established. Additionally, breastfeeding women are advised to avoid this medication if possible, or to discontinue breastfeeding if taking it, as it may be excreted in breast milk. This medication's safety has not been sufficiently established in children, and experience in pediatric use is limited, so caution is advised. This medication should be kept out of the reach of children, and transferring it to another container may lead to degradation of quality or incidents, so it’s safest to store it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air or moisture, and at a temperature between 1°C and 30°C at room temperature. Proper storage will help maintain the medication's effectiveness and safety.
White, round tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIrsogladine Maleate 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Orally disintegrating Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Dong-gu Bio Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Ilyun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
(Co., Ltd.) Nexpharm Korea
Irsogladine Maleate 2mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.